GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTC Bio Inc (XKRX:060590) » Definitions » Additional Paid-In Capital

CTC Bio (XKRX:060590) Additional Paid-In Capital : ₩120,863 Mil(As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is CTC Bio Additional Paid-In Capital?


CTC Bio's quarterly additional paid-in capital stayed the same from Sep. 2023 (₩120,863 Mil) to Dec. 2023 (₩120,863 Mil) and stayed the same from Dec. 2023 (₩120,863 Mil) to Mar. 2024 (₩120,863 Mil).

CTC Bio's annual additional paid-in capital increased from Dec. 2021 (₩116,726 Mil) to Dec. 2022 (₩120,863 Mil) but then stayed the same from Dec. 2022 (₩120,863 Mil) to Dec. 2023 (₩120,863 Mil).


CTC Bio Additional Paid-In Capital Historical Data

The historical data trend for CTC Bio's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTC Bio Additional Paid-In Capital Chart

CTC Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83,982.14 103,284.84 116,726.27 120,863.00 120,863.00

CTC Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 121,897.27 120,863.00 120,863.00 120,863.00 120,863.00

CTC Bio Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

CTC Bio Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of CTC Bio's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


CTC Bio (XKRX:060590) Business Description

Traded in Other Exchanges
N/A
Address
94, Saengmyeonggwahakgwan-gil, Gangwon-do, Hongcheon, KOR, 25142
CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.

CTC Bio (XKRX:060590) Headlines

No Headlines